{"id":20600,"date":"2021-12-16T12:05:27","date_gmt":"2021-12-16T11:05:27","guid":{"rendered":"https:\/\/www.mannheimerswartling.se\/?p=20600"},"modified":"2024-05-29T15:54:43","modified_gmt":"2024-05-29T13:54:43","slug":"carasent-forvarvar-medrave-software","status":"publish","type":"post","link":"https:\/\/www.mannheimerswartling.se\/uppdrag\/carasent-forvarvar-medrave-software\/","title":{"rendered":"Carasent f\u00f6rv\u00e4rvar Medrave Software"},"content":{"rendered":"<p class=\"preamble\">Carasent ASA har f\u00f6rv\u00e4rvat Medrave Software AB. Medrave \u00e4r en skandinavisk marknadsledare inom mjukvara f\u00f6r kvalitetsf\u00f6rb\u00e4ttring f\u00f6r h\u00e4lso- och sjukv\u00e5rdsverksamheter inom prim\u00e4rv\u00e5rd och specialistv\u00e5rd.<\/p>\n<p>Medraves modulbaserade mjukvara tillhandah\u00e5ller klinisk information till v\u00e5rdgivare. Kvalitetsverktyget samlar och sorterar automatiskt data, analyserar och visualiserar, sp\u00e5rar och j\u00e4mf\u00f6r KPI, samt tillhandah\u00e5ller automatisk rapportering. Medrave har en kundbas med mer \u00e4n 260 kunder i Sverige och Norge, f\u00f6rdelade p\u00e5 1 646 v\u00e5rdenheter och uppskattningsvis 8,8 miljoner patienter.<\/p>\n<p>Carasent ASA fokuserar p\u00e5 utvecklingsbolag och e-h\u00e4lsotj\u00e4nster p\u00e5 den skandinaviska marknaden. Bolaget \u00e4r noterat p\u00e5 Oslob\u00f6rsen.<\/p>\n<p>Mannheimer Swartling var legal r\u00e5dgivare till Carasent ASA i transaktionen.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Carasent ASA har f\u00f6rv\u00e4rvat Medrave Software AB. Medrave \u00e4r en skandinavisk marknadsledare inom mjukvara f\u00f6r kvalitetsf\u00f6rb\u00e4ttring f\u00f6r h\u00e4lso- och sjukv\u00e5rdsverksamheter inom prim\u00e4rv\u00e5rd och specialistv\u00e5rd. Medraves\u2026<\/p>\n","protected":false},"author":11,"featured_media":20316,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3469],"tags":[],"class_list":["post-20600","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uppdrag","business-group-foretagsoverlatelser","business-group-healthcare-and-life-sciences","business-group-it-tech"],"acf":[],"lang":"sv","translations":{"sv":20600,"en":20602},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/20600"}],"collection":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/comments?post=20600"}],"version-history":[{"count":1,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/20600\/revisions"}],"predecessor-version":[{"id":20601,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/20600\/revisions\/20601"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media\/20316"}],"wp:attachment":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media?parent=20600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/categories?post=20600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/tags?post=20600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}